| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.3M | -79.4% |
| R&D Expense | $157.6M | +0.3% |
| SG&A Expense | $117.8M | +33.2% |
| Operating Income | -$253.1M | -84.0% |
| Pre-tax Income | -$228.9M | -117.4% |
| Income Tax | $69K | -96.7% |
| Net Income | -$228.9M | -113.3% |
| EPS (Basic) | -$4.07 | -103.5% |
| EPS (Diluted) | -$4.07 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.3M | -24.1% |
| Short-term Investments | $370.1M | -23.2% |
| Current Assets | $462.2M | -22.9% |
| Total Assets | $604.0M | -15.1% |
| Current Liabilities | $104.2M | -16.9% |
| Total Liabilities | $201.6M | -21.4% |
| Stockholders' Equity | $402.4M | -11.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$210.3M | -151.9% |
| Capital Expenditures | $2.3M | -82.7% |
| Investing Cash Flow | $86.3M | +147.1% |
| Financing Cash Flow | $98.5M | +509.1% |
| Free Cash Flow | -$212.6M | -119.4% |
| -103.5% |